ANDA 207952

TEVA PHARMS USA

FDA Drug Application

Application #207952

Documents

• Letter: 2017-02-15

Application Sponsors

ANDA 207952

TEVA PHARMS USA

Marketing Status

• Prescription: 001

Application Products

001

TABLET;ORAL

30MG

0

LOGILIA

ULIPRISTAL ACETATE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2017-02-13

STANDARD

Submissions Property Types

ORIG

1

Null

15

TE Codes

001

Prescription

AB

CDER Filings

TEVA PHARMS USA

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 207952
            [companyName] => TEVA PHARMS USA
            [docInserts] => ["",""]
            [products] => [{"drugName":"LOGILIA","activeIngredients":"ULIPRISTAL ACETATE","strength":"30MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/13\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/207952Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-02-13
        )

)